It’s important to maintain a temperature of 77 degrees or cooler, and above freezing, so efficacy is highest when the product ...

Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...

The chronic and progressive inflammatory disease bronchiectasis is characterised by permanent bronchi dilation and by ...

The Animal Antibacterial and Antibiotics Market is being driven by several key factors. Rising livestock production and ...

Report on how AI is redefining market landscape - The Global Gastrointestinal Diseases Therapeutics Market size is es ...

Boehringer Ingelheim has entered a partnership with the NCD Alliance ... Please be aware that information relating to the approval status and labels of approved products may vary from country to ...

The U.S. FDA Breakthrough Therapy designation is for the treatment of adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) and moderate or advanced fibrosis, based on surv ...

German family-owned pharma major Boehringer Ingelheim and USA-based Circle Pharma (have entered into a research collaboration and license agreement with the shared goal to develop a first-in-class ...

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for survodutide (BI 456906), which is ...

The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent by ...